2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 731 | 835 | 722 | 870 | 727 | 217 | 91 | 61 | 81 | 400 |
Total Income - EUR | 731 | 835 | 722 | 870 | 727 | 217 | 91 | 61 | 81 | 400 |
Total Expenses - EUR | 389 | 511 | 615 | 556 | 521 | 750 | 482 | 362 | 318 | 2.034 |
Gross Profit/Loss - EUR | 342 | 324 | 108 | 315 | 207 | -532 | -391 | -302 | -237 | -1.634 |
Net Profit/Loss - EUR | 319 | 299 | 86 | 288 | 184 | -539 | -394 | -303 | -237 | -1.634 |
Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Homeomed S.r.l.
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 585 | 427 | 275 | 129 | 0 | 0 | 0 |
Current Assets | 134 | 356 | 438 | 19 | 94 | 5 | 13 | 2 | 47 | 163 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 134 | 356 | 438 | 19 | 94 | 5 | 13 | 2 | 47 | 163 |
Shareholders Funds | 129 | 352 | 432 | 340 | 518 | -31 | -424 | -728 | -964 | -6.400 |
Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 200 |
Debts | 5 | 4 | 6 | 264 | 3 | 311 | 566 | 730 | 1.011 | 6.563 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Homeomed S.r.l.